🇺🇸 FDA
Patent

US 7893299

Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators

granted A61PA61P1/02A61P1/16

Quick answer

US patent 7893299 (Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators) held by The Regents of the University of California expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/02, A61P1/16, A61P11/02, A61P17/00